vs

Side-by-side financial comparison of LifeStance Health Group, Inc. (LFST) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Real Brokerage Inc is the larger business by last-quarter revenue ($568.5M vs $382.2M, roughly 1.5× LifeStance Health Group, Inc.). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs -0.1%, a 3.1% gap on every dollar of revenue. On growth, Real Brokerage Inc posted the faster year-over-year revenue change (52.6% vs 17.4%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $8.4M).

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

LFST vs REAX — Head-to-Head

Bigger by revenue
REAX
REAX
1.5× larger
REAX
$568.5M
$382.2M
LFST
Growing faster (revenue YoY)
REAX
REAX
+35.2% gap
REAX
52.6%
17.4%
LFST
Higher net margin
LFST
LFST
3.1% more per $
LFST
3.1%
-0.1%
REAX
More free cash flow
LFST
LFST
$38.2M more FCF
LFST
$46.6M
$8.4M
REAX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
LFST
LFST
REAX
REAX
Revenue
$382.2M
$568.5M
Net Profit
$11.7M
$-447.0K
Gross Margin
7.9%
Operating Margin
4.7%
-0.1%
Net Margin
3.1%
-0.1%
Revenue YoY
17.4%
52.6%
Net Profit YoY
264.1%
82.7%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFST
LFST
REAX
REAX
Q4 25
$382.2M
Q3 25
$363.8M
$568.5M
Q2 25
$345.3M
$540.7M
Q1 25
$333.0M
$354.0M
Q4 24
$325.5M
Q3 24
$312.7M
$372.5M
Q2 24
$312.3M
Q1 24
$300.4M
$200.7M
Net Profit
LFST
LFST
REAX
REAX
Q4 25
$11.7M
Q3 25
$1.1M
$-447.0K
Q2 25
$-3.8M
$1.5M
Q1 25
$709.0K
$-5.0M
Q4 24
$-7.1M
Q3 24
$-6.0M
$-2.6M
Q2 24
$-23.3M
Q1 24
$-21.1M
$-16.1M
Gross Margin
LFST
LFST
REAX
REAX
Q4 25
Q3 25
7.9%
Q2 25
8.9%
Q1 25
9.6%
Q4 24
Q3 24
8.6%
Q2 24
Q1 24
10.3%
Operating Margin
LFST
LFST
REAX
REAX
Q4 25
4.7%
Q3 25
2.0%
-0.1%
Q2 25
-0.9%
0.3%
Q1 25
0.5%
-1.5%
Q4 24
0.3%
Q3 24
0.0%
-0.7%
Q2 24
-5.1%
Q1 24
-5.6%
-7.8%
Net Margin
LFST
LFST
REAX
REAX
Q4 25
3.1%
Q3 25
0.3%
-0.1%
Q2 25
-1.1%
0.3%
Q1 25
0.2%
-1.4%
Q4 24
-2.2%
Q3 24
-1.9%
-0.7%
Q2 24
-7.5%
Q1 24
-7.0%
-8.0%
EPS (diluted)
LFST
LFST
REAX
REAX
Q4 25
Q3 25
$0.00
Q2 25
$0.01
Q1 25
$-0.02
Q4 24
Q3 24
$-0.01
Q2 24
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFST
LFST
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$248.6M
$38.7M
Total DebtLower is stronger
$282.8M
Stockholders' EquityBook value
$1.5B
$53.6M
Total Assets
$2.2B
$145.2M
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFST
LFST
REAX
REAX
Q4 25
$248.6M
Q3 25
$203.9M
$38.7M
Q2 25
$188.9M
$49.7M
Q1 25
$134.3M
$24.7M
Q4 24
$154.6M
Q3 24
$102.6M
$22.6M
Q2 24
$87.0M
Q1 24
$49.5M
$20.1M
Total Debt
LFST
LFST
REAX
REAX
Q4 25
$282.8M
Q3 25
$284.6M
Q2 25
$286.4M
Q1 25
$288.2M
Q4 24
$290.0M
Q3 24
$287.3M
Q2 24
$288.0M
Q1 24
$288.8M
Stockholders' Equity
LFST
LFST
REAX
REAX
Q4 25
$1.5B
Q3 25
$1.5B
$53.6M
Q2 25
$1.5B
$49.2M
Q1 25
$1.5B
$32.8M
Q4 24
$1.4B
Q3 24
$1.4B
$29.8M
Q2 24
$1.4B
Q1 24
$1.4B
$25.6M
Total Assets
LFST
LFST
REAX
REAX
Q4 25
$2.2B
Q3 25
$2.1B
$145.2M
Q2 25
$2.1B
$149.4M
Q1 25
$2.1B
$100.5M
Q4 24
$2.1B
Q3 24
$2.1B
$102.5M
Q2 24
$2.1B
Q1 24
$2.1B
Debt / Equity
LFST
LFST
REAX
REAX
Q4 25
0.19×
Q3 25
0.19×
Q2 25
0.19×
Q1 25
0.20×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.20×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFST
LFST
REAX
REAX
Operating Cash FlowLast quarter
$57.6M
$8.8M
Free Cash FlowOCF − Capex
$46.6M
$8.4M
FCF MarginFCF / Revenue
12.2%
1.5%
Capex IntensityCapex / Revenue
2.9%
0.1%
Cash ConversionOCF / Net Profit
4.93×
TTM Free Cash FlowTrailing 4 quarters
$110.0M
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFST
LFST
REAX
REAX
Q4 25
$57.6M
Q3 25
$27.3M
$8.8M
Q2 25
$64.4M
$41.0M
Q1 25
$-3.1M
$15.9M
Q4 24
$62.3M
Q3 24
$22.7M
$7.2M
Q2 24
$44.1M
Q1 24
$-21.8M
$21.5M
Free Cash Flow
LFST
LFST
REAX
REAX
Q4 25
$46.6M
Q3 25
$17.0M
$8.4M
Q2 25
$56.6M
$40.8M
Q1 25
$-10.3M
$15.7M
Q4 24
$56.0M
Q3 24
$17.7M
$6.8M
Q2 24
$39.0M
Q1 24
$-26.9M
$21.4M
FCF Margin
LFST
LFST
REAX
REAX
Q4 25
12.2%
Q3 25
4.7%
1.5%
Q2 25
16.4%
7.5%
Q1 25
-3.1%
4.4%
Q4 24
17.2%
Q3 24
5.7%
1.8%
Q2 24
12.5%
Q1 24
-9.0%
10.7%
Capex Intensity
LFST
LFST
REAX
REAX
Q4 25
2.9%
Q3 25
2.8%
0.1%
Q2 25
2.2%
0.0%
Q1 25
2.2%
0.1%
Q4 24
1.9%
Q3 24
1.6%
0.1%
Q2 24
1.6%
Q1 24
1.7%
0.0%
Cash Conversion
LFST
LFST
REAX
REAX
Q4 25
4.93×
Q3 25
25.34×
Q2 25
27.13×
Q1 25
-4.36×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons